OrthoPediatrics Corp. (KIDS)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-09
$21.68-2.43%
Close 2026-09-09 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-09
Warn: Management is running behind on a stated commitment.
OrthoPediatrics aims for $265 million revenue in 2026. The company targets $25 million adjusted EBITDA in 2026. It plans to reach breakeven free cash flow by year-end. Recent earnings beats show some operational progress.
The company is still loss-making with negative cash flow. Revenue growth and cash flow targets are ambitious given current Q1 results. Failure to improve profitability could continue to pressure the stock.
The price is about 55% below our fair value near $45. Analysts expect 14% revenue growth, which aligns with management guidance. Our view is cautious due to ongoing losses and cash flow challenges.
Breaks if: Adjusted EBITDA remains negative or below $15 million in FY26
Breaks if: Free cash flow remains negative beyond FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story in the healthcare sector. KIDS is currently loss-making but is working towards improving its financial performance and achieving key management goals.
The market appears to have priced in a low level of fragility, suggesting that expectations are somewhat justified. KIDS is seen as cheap compared to its peers, but there is a notable expectations gap.
Management is on track to increase revenue and improve adjusted EBITDA, though achieving breakeven free cash flow remains a mixed priority. Recent financial performance has been neutral, with a low probability of missing expectations in the near term.
The long-term thesis hinges on KIDS maintaining its revenue growth trajectory and successfully navigating potential risks, such as sector performance and economic conditions. Key scenarios include the impact of guidance changes and broader healthcare sector momentum.
The most important moves since the prior daily snapshot.
Signal changed from 'mild_favorable' to 'favorable'.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Target to achieve breakeven free cash flow for full year 2026 to improve cash generation.
Stated as a priority in 2 of last 2 quarters. Free cash flow usage improved significantly from $8.4 million used in 2026-Q1 to $3.1 million used in 2026-Q2, a 78% improvement year-over-year. The Company reiterated its goal to achieve breakeven free cash flow in 2026. The trajectory shows meaningful progress but breakeven not yet achieved.
“expects to achieve breakeven free cash flow in 2026”
“expects to achieve breakeven free cash flow in 2026”
Breaks if: Revenue falls below $233 million in FY26
Overall, KIDS is in a stable position but faces elevated risks that could affect its trajectory. Not investment advice.